Subacute endotoxemia induces adipose inflammation and changes in lipid and lipoprotein metabolism in cats

Endocrinology

Volumn 152, Issue 3, 2011, Pages 804-815

  Osto, M ^a   Zini, E ^a   Franchini, M ^a   Wolfrum, C ^b   Guscetti, F ^a   Hafner, M ^a   Ackermann, M ^a   Reusch, C E ^a   Lutz, Thomas A ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b ETH ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE TRANSPORTER 4; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN RECEPTOR SUBSTRATE 1; LIPOPOLYSACCHARIDE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA1; SODIUM CHLORIDE; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY TEMPERATURE; DISEASE SEVERITY; DOWN REGULATION; ENDOTOXEMIA; ENZYME ACTIVITY; EXPERIMENTAL CAT; GLUCOSE METABOLISM; HOMEOSTASIS; INFLAMMATION; INSULIN METABOLISM; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID METABOLISM; LIPOPROTEIN METABOLISM; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS INSUFFICIENCY; PRIORITY JOURNAL;

ADIPOSE TISSUE; ANIMALS; CATS; ENDOTOXEMIA; GENE EXPRESSION REGULATION; INFLAMMATION; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; LIPID METABOLISM; LIPOPOLYSACCHARIDES; LIPOPROTEINS; MALE;

EID: 79951900664     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2010-0999     Document Type: Article

References (59)

1. Shoelson SE, Lee J, Goldfine AB 2006 Inflammation and insulin resistance. J Clin Invest 116:1793-1801 (Pubitemid 44033299)
2. Wellen KE, Hotamisligil GS 2005 Inflammation, stress, and diabetes. J Clin Invest 115:1111-1119 (Pubitemid 40629025)
3. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante Jr AW 2003 Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112:1796-1808 (Pubitemid 38063703)
4. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H 2003 Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112:1821-1830 (Pubitemid 38063705)
5. Kim F, Pham M, Luttrell I, Bannerman DD, Tupper J, Thaler J, Hawn TR, Raines EW, Schwartz MW 2007 Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity. Circ Res 100:1589-1596 (Pubitemid 46897262)
6. Saltiel AR, Kahn CR 2001 Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414:799-806 (Pubitemid 34000783)
7. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM 1996 IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α- and obesity-induced insulin resistance. Science (NY) 271:665-668 (Pubitemid 26052915)
8. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS 2006 TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 116:3015-3025 (Pubitemid 44684486)
9. Shulman GI 2000 Cellular mechanisms of insulin resistance. J Clin Invest 106:171-176 (Pubitemid 30483118)
10. Agwunobi AO, Reid C, Maycock P, Little RA, Carlson GL 2000 Insulin resistance and substrate utilization in human endotoxemia. J Clin Endocrinol Metab 85:3770-3778
11. Virkamäki A, Yki-Järvinen H 1994 Mechanisms of insulin resistance during acute endotoxemia. Endocrinology 134:2072-2078 (Pubitemid 24142945)
12. Anderson PD, Mehta NN, Wolfe ML, Hinkle CC, Pruscino L, Comiskey LL, Tabita-Martinez J, Sellers KF, Rickels MR, Ahima RS, Reilly MP 2007 Innate immunity modulates adipokines in humans. J Clin Endocrinol Metab 92:2272-2279 (Pubitemid 46997133)
13. DeClue AE, Williams KJ, Sharp C, Haak C, Lechner E, Reinero CR 2009 Systemic response to low-dose endotoxin infusion in cats. Vet Immunol Immunopathol 132:167-174
14. Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, Neyrinck AM, Fava F, Tuohy KM, Chabo C, Waget A, Delmée E, Cousin B, Sulpice T, Chamontin B, Ferrières J, Tanti JF, Gibson GR, Casteilla L, Delzenne NM, Alessi MC, Burcelin R 2007 Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56:1761-1772 (Pubitemid 47025442)
15. Lutz TA, Rand JS 1995 Pathogenesis of feline diabetes mellitus. Vet Clin North Am 25:527-552
16. Lutz TA, Rand JS 1997 Detection of amyloid deposition in various regions of the feline pancreas by different staining techniques. J Comp Pathol 116:157-170 (Pubitemid 27139888)
17. Zini E, Osto M, Franchini M, Guscetti F, Donath MY, Perren A, Heller RS, Linscheid P, Bouwman M, Ackermann M, Lutz TA, Reusch CE 2009 Hyperglycaemia but not hyperlipidaemia causes β cell dysfunction and β cell loss in the domestic cat. Diabetologia 52:336-346
18. Zini E, Osto M, Konrad D, Franchini M, Sieber-Ruckstuhl NS, Kaufmann K, Guscetti F, Ackermann M, Lutz TA, Reusch CE 2010 10-day hyperlipidemic clamp in cats: effects on insulin sensitivity, inflammation, and glucose metabolism-related genes. Horm Metab Res 42:340-347
19. Rand JS, Fleeman LM, Farrow HA, Appleton DJ, Lederer R 2004 Canine and feline diabetes mellitus: nature or nurture? J Nutr 134: 2072S-2080S
20. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC 1985 Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419 (Pubitemid 15018832)
21. Appleton DJ, Rand JS, Sunvold GD 2005 Basal plasma insulin and homeostasis model assessment (HOMA) are indicators of insulin sensitivity in cats. J Feline Med Surg 7:183-193 (Pubitemid 40716484)
22. Slingerland LI, Robben JH, van Haeften TW, Kooistra HS, Rijnberk A 2007 Insulin sensitivity and β-cell function in healthy cats: assessment with the use of the hyperglycemic glucose clamp. Horm Metab Res 39:341-346 (Pubitemid 46877849)
23. Matsuda M, DeFronzo RA 1999 Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:1462-1470 (Pubitemid 29418240)
24. Wareham NJ, Phillips DI, Byrne CD, Hales CN 1995 The 30 minute insulin incremental response in an oral glucose tolerance test as a measure of insulin secretion. Diabet Med 12:931
25. Zini E, Franchini M, Guscetti F, Osto M, Kaufmann K, Ackermann M, Lutz TA, Reusch CE 2009 Assessment of six different collagenase-based methods to isolate feline pancreatic islets. Res Vet Sci 87:367-372
26. Franchini M, Zini E, Osto M, Jablonski K, Kaufmann K, Lutz TA, Reusch CE, Ackermann M 2010 Feline pancreatic islet-like clusters and insulin producing cells express functional Toll-like receptors (TLRs). Vet Immunol Immunopathol 138:70-78
27. Zini E, Linscheid P, Franchini M, Kaufmann K, Monnais E, Kutter AP, Ackermann M, Lutz TA, Reusch CE 2009 Partial sequencing and expression of genes involved in glucose metabolism in adipose tissues and skeletal muscle of healthy cats. Vet J 180:66-70
28. Grillo CA, Piroli GG, Hendry RM, Reagan LP 2009 Insulin-stimulated translocation of GLUT4 to the plasma membrane in rat hippocampus is PI3-kinase dependent. Brain Res 1296:35-45
29. Schweiger M, Schreiber R, Haemmerle G, Lass A, Fledelius C, Jacobsen P, Tornqvist H, Zechner R, Zimmermann R 2006 Adipose triglyceride lipase and hormone-sensitive lipase are the major enzymes in adipose tissue triacylglycerol catabolism. J Biol Chem 281:40236-40241 (Pubitemid 46041828)
30. Ceron JJ, Eckersall PD, Martýnez-Subiela S 2005 Acute phase proteins in dogs and cats: current knowledge and future perspectives. Vet Clin Pathol 34:85-99 (Pubitemid 40799488)
31. Yang RZ, Lee MJ, Hu H, Pollin TI, Ryan AS, Nicklas BJ, Snitker S, Horenstein RB, Hull K, Goldberg NH, Goldberg AP, Shuldiner AR, Fried SK, Gong DW 2006 Acute-phase serum amyloid A: an inflammatory adipokine and potential link between obesity and its metabolic complications. PLoS Med 3:e287
32. Strissel KJ, Stancheva Z, Miyoshi H, Perfield 2nd JW, DeFuria J, Jick Z, Greenberg AS, Obin MS 2007 Adipocyte death, adipose tissue remodeling, and obesity complications. Diabetes 56:2910-2918 (Pubitemid 350223625)
33. Draisma A, Pickkers P, Bouw MP, van der Hoeven JG 2009 Development of endotoxin tolerance in humans in vivo. Crit Care Med 37:1261-1267
34. Mehta NN, McGillicuddy FC, Anderson PD, Hinkle CC, Shah R, Pruscino L, Tabita-Martinez J, Sellers KF, Rickels MR, Reilly MP 2010 Experimental endotoxemia induces adipose inflammation and insulin resistance in humans. Diabetes 59:172-181
35. Zhong B, Ma HY, Yang Q, Gu FR, Yin GQ, Xia CM 2008 Decrease in toll-like receptors 2 and 4 in the spleen of mouse with endotoxic tolerance. Inflamm Res 57:252-259
36. Wellen KE, Hotamisligil GS 2003 Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 112:1785-1788 (Pubitemid 38063699)
37. Hoenig M, Thomaseth K, Waldron M, Ferguson DC 2007 Insulin sensitivity, fat distribution, and adipocytokine response to different diets in lean and obese cats before and after weight loss. Am J Physiol 292:R227-R234 (Pubitemid 46089834)
38. Mészáros K, Lang CH, Bagby GJ, Spitzer JJ 1988 In vivo glucose utilization by individual tissues during nonlethal hypermetabolic sepsis. FASEB J 2:3083-3086
39. Li L, Messina JL 2009 Acute insulin resistance following injury. Trends Endocrinol Metab 20:429-435
40. Dahn MS, Lange P 1982 Hormonal changes and their influence on metabolism and nutrition in the critically ill. Intensive Care Med 8:209-213 (Pubitemid 12046013)
41. Van der Poll T, Romijn JA, Endert E, Borm JJ, Büller HR, Sauerwein HP 1991 Tumor necrosis factor mimics the metabolic response to acute infection in healthy humans. Am J Physiol 261:E457-E465
42. Hirosumi J, Tuncman G, Chang L, Görgün CZ, Uysal KT, Maeda K, Karin M, Hotamisligil GS 2002 A central role for JNK in obesity and insulin resistance. Nature 420:333-336 (Pubitemid 35398190)
43. Karasik A, Rothenberg PL, Yamada K, White MF, Kahn CR 1990 Increased protein kinase C activity is linked to reduced insulin receptor autophosphorylation in liver of starved rats. J Biol Chem 265:10226-10231
44. Ueki K, Kondo T, Kahn CR 2004 Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms. Mol Cell Biol 24:5434-5446 (Pubitemid 38738176)
45. Brennan CL, Hoenig M, Ferguson DC 2004 GLUT4 but not GLUT1 expression decreases early in the development of feline obesity. Domest Anim Endocrinol 26:291-301 (Pubitemid 38448852)
46. Rosen ED, Spiegelman BM 2001 PPARγ: a nuclear regulator of metabolism, differentiation, and cell growth. J Biol Chem 276:37731-37734
47. Anthony NM, Gaidhu MP, Ceddia RB 2009 Regulation of visceral and subcutaneous adipocyte lipolysis by acute AICAR-induced AMPK activation. Obesity 17:1312-1317
48. Zhang HH, Halbleib M, Ahmad F, Manganiello VC, Greenberg AS 2002 Tumor necrosis factor-α stimulates lipolysis in differentiated human adipocytes through activation of extracellular signal-related kinase and elevation of intracellular cAMP. Diabetes 51:2929-2935
49. Memon RA, Fuller J, Moser AH, Smith PJ, Feingold KR, Grunfeld C 1998 In vivo regulation of acyl-CoA synthetase mRNA and activity by endotoxin and cytokines. Am J Physiol 275:E64-E72
50. Itani SI, Ruderman NB, Schmieder F, Boden G 2002 Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IκB-α. Diabetes 51:2005-2011 (Pubitemid 34729001)
51. McLaughlin T, Deng A, Yee G, Lamendola C, Reaven G, Tsao PS, Cushman SW, Sherman A 2010 Inflammation in subcutaneous adipose tissue: relationship to adipose cell size. Diabetologia 53:369-377
52. Memon RA, Bass NM, Moser AH, Fuller J, Appel R, Grunfeld C, Feingold KR 1999 Down-regulation of liver and heart specific fatty acid binding proteins by endotoxin and cytokines in vivo. Biochim Biophys Acta 1440:118-126 (Pubitemid 29406155)
53. Kim MS, Sweeney TR, Shigenaga JK, Chui LG, Moser A, Grunfeld C, Feingold KR 2007 Tumor necrosis factor and interleukin 1 decrease RXRα, PPARα, PPARγ, LXRα, and the coactivators SRC-1, PGC-1α, and PGC-1β in liver cells. Metabolism 56:267-279 (Pubitemid 46084934)
54. Korenblat KM, Fabbrini E, Mohammed BS, Klein S 2008 Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects. Gastroenterology 134:1369-1375 (Pubitemid 351615354)
55. Khovidhunkit W, Kim MS, Memon RA, Shigenaga JK, Moser AH, Feingold KR, Grunfeld C 2004 Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J Lipid Res 45:1169-1196 (Pubitemid 38802622)
56. Jordan E, Kley S, Le NA, Waldron M, Hoenig M 2008 Dyslipidemia in obese cats. Domest Anim Endocrinol 35:290-299
57. Fraunberger P, Schaefer S, Werdan K, Walli AK, Seidel D 1999 Reduction of circulating cholesterol and apolipoprotein levels during sepsis. Clin Chem Lab Med 37:357-362 (Pubitemid 29209752)
58. Rohrer L, Hersberger M, von Eckardstein A 2004 High density lipoproteins in the intersection of diabetes mellitus, inflammation and cardiovascular disease. Curr Opin Lipidol 15:269-278 (Pubitemid 38716559)
59. Van Lenten BJ, Hama SY, de Beer FC, Stafforini DM, McIntyre TM, Prescott SM, La Du BN, Fogelman AM, Navab M 1995 Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. J Clin Invest 96:2758-2767